Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease

Angiology

Volumn 60, Issue 2, 2009, Pages 180-185

  Liu, Wenwei ^a,b   Tang, Qizhu ^b   Jiang, Hua ^a   Ding, Xiangwu ^a   Liu, Yongsheng ^a   Zhu, Rui ^a   Tang, Yongqian ^a   Li, Bin ^a   Wei, Min ^a  

^a Xiangfan Central Hospital   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Angiography; Coronary artery disease; Interleukin 18; Polymorphism

Indexed keywords

INTERLEUKIN 18;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL;

ALLELES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES;

EID: 65249126723     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708319939     Document Type: Article

References (33)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126.
2. Lusis AJ Atherosclerosis. Nature. 2000 ; 407 (6801). 233-241.
3. Libby P. Inflammation in atherosclerosis. Nature. 2002 ; 420: 868-874. (Pubitemid 36019640)
4. Armstrong EJ, Morrow DA, Sabatine MS Inflammatory biomarkers in acute coronary syndromes. Part I: introduction and cytokines. Circulation. 2006 ; 113 (6). e72-75.
5. Koenig W., Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007 ; 27 (1). 15-26. (Pubitemid 46360377)
6. Anderson JL, Carlquist JF Cytokines, interleukin-18, and the genetic determinants of vascular inflammation. Circulation. 2005 ; 112 (5). 620-623. (Pubitemid 41099039)
7. Dinarello CA Interleukin-18. Methods. 1999 ; 19: 121-132. (Pubitemid 29497762)
8. Okamura H., Tsutsi H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995 ; 378: 88-91.
9. Gupta S., Pablo AM, Jiang X., et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 1997 ; 99: 2752-2761. (Pubitemid 27259823)
10. Maffia P., Grassia G., Di Meglio P., et al. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation. 2006 ; 114 (5). 430-437. (Pubitemid 44264825)
11. Chandrasekar B., Vemula K., Surabhi RM, et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J Biol Chem. 2004 ; 279 (19). 20221-20233. (Pubitemid 38623467)
12. Chandrasekar B., Valente AJ, et al. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation. Biochem Biophys Res Commun. 2006 ; 339 (3). 956-963. (Pubitemid 41772904)
13. Chandrasekar B., Mummidi S., Mahimainathan L., et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem. 2006 ; 281 (22). 15099-15109. (Pubitemid 43855099)
14. Whitman SC, Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res. 2002 ; 90 (2). E34-38.
15. de Nooijer R., von der Thusen J., Verkleij C., et al. Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol. 2004 ; 24: 2313-2319. (Pubitemid 39658035)
16. Mallat Z., Henry P., Fressonnet R., et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart. 2002 ; 88 (5). 467-469. (Pubitemid 35221955)
17. Blankenberg S., Tiret L., Bickel C., et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002 ; 106 (1). 24-30. (Pubitemid 34747437)
18. Blankenberg S., Luc G., Ducimetire P., et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2003 ; 108 (20). 2453-2459. (Pubitemid 37444405)
19. Mallat Z., Corbaz A., Scoazec A., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001 ; 104: 1598-1603. (Pubitemid 32947520)
20. Gerdes N., Sukhova GK, Libby P., et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med. 2002 ; 195: 245-257. (Pubitemid 34461268)
21. Zirlik A., Abdullah SM, Gerdes N., et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2007 ; 27 (9). 2043-2049. (Pubitemid 47312316)
22. Tiret L., Godefroy T., Lubos E., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation. 2005 ; 112 (5). 643-650. (Pubitemid 41099042)
23. Frayling TM, Rafiq S., Murray A., et al. An interleukin-18 polymorphism is associated with reduced serum concentrations and better physical functioning in older people. J Gerontol A Biol Sci Med Sci. 2007 ; 62 (1). 73-78. (Pubitemid 46931550)
24. Arimitsu J., Hirano T., Higa S., et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun. 2006 ; 342 (4). 1413-1416.
25. Giedraitis V., He B., Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001 ; 112 (1-2). 146-152.
26. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999 ; 33 (6). 1756-1824.
27. Miller SA, Dykes DD, Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 ; 16 (3). 1215.
28. Espinola-Klein C., Rupprecht HJ, Bickel C., et al. Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis. 2007 ; 1: 1. (Pubitemid 350087963)
29. Rosso R., Roth A., Herz I., Miller H., Keren G., George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol. 2005 ; 98: 45-48. (Pubitemid 40169851)
30. Koenig W., Khuseyinova N., Baumert J., Thorand B., Loewel H., Chambless L., Meisinger C., Schneider A., Martin S., Kolb H., Herder C. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol. 2006 ; 26 (12). 2745-2751.
31. Hulthe J., McPheat W., Samnegard A., et al. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis. 2006 ; 4: 4. (Pubitemid 44313924)
32. Liang XH, Cheung W., Heng CK, Wang de Y. Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun. 2005 ; 338: 736-741.
33. Hernesniemi JA, Karhunen PJ, Rontu R., et al. Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study. Atherosclerosis. 2008 ; 196 (2). 643-649.